NCT00064259 2021-02-17
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
National Cancer Institute (NCI)
Phase 1/2 Terminated
Clinical Trials
9 trialsNCT00072332 2013-12-19
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00077545 2013-10-08
3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002897 2013-09-20
Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
National Cancer Institute (NCI)
Phase 3 Completed
NCT00766480 2013-08-26
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
National Cancer Institute (NCI)
Phase NA Unknown
NCT00002884 2013-08-07
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00629863 2013-08-07
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00659113 2011-12-06
S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00075738 2008-07-24
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown